The incidence and risk of venous thromboembolism associated with peripherally inserted central venous catheters in hospitalized patients: a systematic review and …

A Puri, H Dai, M Giri, C Wu, H Huang… - Frontiers in …, 2022 - frontiersin.org
Background Venous thromboembolism (VTE) can be fatal if not treated promptly, and
individual studies have reported wide variability in rates of VTE associated with peripherally …

Complications of central venous access devices used in palliative care settings for terminally ill cancer patients: a systematic review and meta-analysis

CCH Wong, HCW Choi, VHF Lee - Cancers, 2023 - mdpi.com
Simple Summary Common central venous access devices (CVADs) include peripherally
inserted central catheters (PICCs), central lines, and totally implanted ports (PORTs) …

Development and validation of a predictive model for peripherally inserted central catheter-related thrombosis in breast cancer patients based on artificial neural …

J Fu, W Cai, B Zeng, L He, L Bao, Z Lin, F Lin… - International Journal of …, 2022 - Elsevier
Background Peripherally inserted central catheters have been extensively applied in clinical
practices. However, they are associated with an increased risk of thrombosis. To improve …

Phase II study of anlotinib in combination with oxaliplatin and capecitabine for patients with RAS/BRAF wild-type metastatic colorectal adenocarcinoma as the first-line …

Y Liu, Q Xiao, J He, H Hu, J Du, Y Zhu, J Chen, Z Liu… - BMC medicine, 2022 - Springer
Background Anlotinib, an oral small molecule tyrosine kinase inhibitor targeting VEGFR
1/2/3, FGFR 1-4, PDGFR a/β, and c-kit, had demonstrated prolonged progression-free …

Clinical characteristics of peripherally inserted central catheter-related complications in cancer patients undergoing chemotherapy: a prospective and observational …

R Liu, H Xu, L Pu, X Xie, H Chen, Z Wu, H Chen… - BMC cancer, 2023 - Springer
Purpose The incidence of peripherally inserted central catheter (PICC)-related
complications is higher in cancer patients than in noncancer patients. However, the pattern …

[HTML][HTML] Smart implanted access port catheter for therapy intervention with pH and lactate biosensors

B Gil, H Ip, P Kassanos, B Lo, GZ Yang… - Materials Today Bio, 2022 - Elsevier
Totally implanted access ports (TIAP) are widely used with oncology patients requiring long
term central venous access for the delivery of chemotherapeutic agents, infusions …

[HTML][HTML] Risk factors for peripherally inserted central catheter (PICC)-associated infections in patients receiving chemotherapy and the preventive effect of a self …

X Liu, S Tao, H Ji, S Chen, Y Gu… - Annals of Palliative …, 2021 - apm.amegroups.org
Background: A peripherally inserted central catheter (PICC) effectively reduces frequent vein
punctures in cancer patients. With increasing clinical applications, PICC-associated …

Clinical factors associated with peripherally inserted central catheters (PICC) related bloodstream infections: a single centre retrospective cohort

K Barrigah-Benissan, J Ory, C Simon, P Loubet… - … Resistance & Infection …, 2023 - Springer
Background Despite their spread in daily practice, few data is available on clinical factors
associated with peripherally inserted central catheter (PICC)-related bloodstream infections …

Assessing the thrombosis risk of peripherally inserted central catheters in cancer patients using Caprini risk assessment model: a prospective cohort study

Y Feng, R Zheng, Y Fu, Q Xiang, Z Yue, J Li… - Supportive Care in …, 2021 - Springer
Purpose There was no optimal risk assessment tool to stratify the risk of peripherally inserted
central catheter-related venous thromboembolism (PICC-RVT) in cancer patients. We …

Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study

H Zhang, Y Li, N Zhu, Y Li, J Fu, J Liu - Scientific Reports, 2022 - nature.com
To compare the efficacy of peripherally inserted central catheters (PICCs) and totally
implantable venous-access ports (TIVAPs) for chemotherapy of pediatric patients with …